Invention Grant
- Patent Title: Chimeric proteins and methods of immunotherapy
-
Application No.: US16029299Application Date: 2018-07-06
-
Publication No.: US10336807B2Publication Date: 2019-07-02
- Inventor: Lei S. Qi , Bing C Wang
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C12N15/63 ; C07K14/725 ; C07K16/00 ; C12N9/22 ; A61P35/00 ; A61K35/17 ; C12N15/10 ; C12N15/90 ; A61K38/00
Abstract:
The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.
Public/Granted literature
- US20180346543A1 Chimeric Proteins and Methods of Immunotherapy Public/Granted day:2018-12-06
Information query
